In August, members of the National Institutes of Health (NIH) Brain Research Through Advancing Innovative Neurotechnologies® (BRAIN) Initiative’s Neuroethics Working Group (NEWG) and Multi-Council Working Group (MCWG) met to discuss ethical considerations related to artificial intelligence (AI) in neuroscience research, as well as updates from NEWG and MCWG members.
Researchers integrate transcranial focused ultrasound with brain-computer interface (BCI) to precisely target parts of the brain and enhance BCI performance.
The BRAIN Initiative is marking a milestone—10 years of advancing neuroscience and neurotechnology research by funding innovative projects. As part of a rotating series of blog posts, the directors of the BRAIN Initiative-partnering NIH Institutes and Centers share their voice and perspectives on the impact BRAIN has made on their respective missions—and vice versa.
By Helene M. Langevin, M.D., Director, NCCIH
1. How has the National Center for Complementary and Integrative Health (NCCIH) participated in the NIH BRAIN Initiative?
An international scientific team unveils a comprehensive neural map of an adult Drosophila melanogaster brain. The BRAIN-funded studies detail more than 50 million connections across 140,000 neurons and appear in nine papers in the journal Nature.
Join us at the upcoming hybrid NIH BRAIN NeuroAI Workshop on November 12 and 13, with virtual access to in-person panels and discussions at the NIH Campus in Bethesda, MD.
Dr. Drew Schreiner is an F32 award recipient who used the funding opportunity to study the neuronal mechanisms that influence songbird learning behavior. The F32 funding opportunity supports the research training of promising postdoctoral fellows early in their postdoctoral training period.
The BRAIN Initiative is marking a milestone—10 years of advancing neuroscience and neurotechnology research by funding innovative projects. As part of a rotating series of blog posts, the directors of the BRAIN Initiative-partnering Institutes and Centers share their voice and perspectives on the impact BRAIN has made on their respective missions—and vice versa.
By Nora Volkow, MD, Director, and Rita Valentino, PhD, Director, Division of Neuroscience and Behavior, NIDA
A small feasibility study funded by the National Institutes of Health (NIH) found that an implanted device regulated by the body’s brain activity could provide continual and improved treatment for the symptoms of Parkinson’s disease (PD) in certain people with the disorder.
Nearly 100 world experts will convene to discuss cutting edge research, technologies, and neuroethical issues within the field of neuromodulation.
